+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antiretroviral"

From
From
From
HIV Drugs - Global Strategic Business Report - Product Thumbnail Image

HIV Drugs - Global Strategic Business Report

  • Report
  • February 2025
  • 164 Pages
  • Global
From
HIV Drugs Market Report 2025 - Product Thumbnail Image

HIV Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
From
From
Diagnostics and Therapeutics for HIV: Global Markets - Product Thumbnail Image

Diagnostics and Therapeutics for HIV: Global Markets

  • Report
  • October 2023
  • 186 Pages
  • Global
From
From
HIV Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

HIV Drugs Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Loading Indicator

The antiretroviral market is a subset of the HIV/AIDS drugs market, which is focused on the development and sale of drugs that can be used to treat HIV/AIDS. Antiretroviral drugs are used to reduce the amount of HIV in the body, and can be used to prevent the transmission of HIV from one person to another. These drugs are typically used in combination with other treatments, such as counseling and lifestyle changes, to help people living with HIV/AIDS manage their condition. The antiretroviral market is highly competitive, with many companies developing and selling drugs to treat HIV/AIDS. Some of the major players in the market include Gilead Sciences, Merck, Bristol-Myers Squibb, GlaxoSmithKline, and ViiV Healthcare. Other companies, such as AbbVie, Janssen, and Mylan, also have a presence in the market. Show Less Read more